These observations, together with the report that high expression of Jagged1 and/or Notch-1 are associated with poor clinical outcomes1 has resulted in an intense interest in exploring Notch signaling as a therapeutic target for breast cancer treatment5,9,10. This evidence concerns the gene NOTCH1 and breast cancer.